New Hepatitis C Drug SIMEPREVIR being reviewed in Canada-needs patient input
New drug being reviewed: simeprevir (similar to boceprevir and telaprevir, but only one pill per day and does not require special food intake). Deadline: midnight, Sept. 11, 2013. Give input at: http://hepcbc.ca/2013/08/urgent-request-for-your-input-into-a-new-hcv-drug-simeprevir/ . THANKS!
New drug being reviewed: simeprevir (similar to boceprevir and telaprevir, but only one pill per day and does not require special food intake). Deadline: midnight, Sept. 11, 2013. Give input at: http://hepcbc.ca/2013/08/urgent-request-for-your-input-into-a-new-hcv-drug-simeprevir/ . THANKS!